Variables | All patients (N = 240) | d | |
---|---|---|---|
No-MNIP Group (n = 120) | MNIP Group (n = 120) | ||
Age | 62.3 ± 8.3 | 63.1 ± 8.2 | 0.23 |
Gender (M) | 64 | 62 | 0.14 |
Tumor state (primary/metastasis) | 102/18 | 99/22 | 0.23 |
Duration of symptom (m) | 3.3 ± 1.3 | 3.1 ± 1.2 | 0.54 |
Chemotherapy (cases) | 62 | 60 | 0.21 |
Radiotherapy (cases) | 24 | 20 | 0.19 |
Pre-SINS score | 8.3 ± 3.1 | 8.6 ± 2.9 | 0.33 |
Operating time (h) | 4.6 ± 2.1 | 4.8 ± 1.1 | 0.21 |
Blood loss (ml) | 1230.5 ± 180.2 | 1250.2 ± 190.5 | 0.31 |
Variables | Marched patients (N = 160) | d | |
---|---|---|---|
No-MNIP Group (n = 80) | MNIP Group (n = 80) | ||
Age | 61.0 ± 5.2 | 60.2 ± 4.9 | |
Gender (M) | 39 | 42 | |
Tumor state (primary/metastasis) | 70/10 | 68/12 | 0.02 |
Duration of symptom (m) | 3.6 ± 1.1 | 3.2 ± 1.5 | 0.01 |
Chemotherapy (cases) | 40 | 38 | 0.03 |
Radiotherapy(cases) | 10 | 12 | 0.16 |
Pre-SINS score | 8.5 ± 2.8 | 8.4 ± 3.1 | 0.01 |
Operating time (min) | 4.5 ± 2.5 | 4.7 ± 2.5 | 0.08 |
Blood loss (ml) | 1300.5 ± 200.2 | 1200.5 ± 180.2 | 0.03 |